Covered recipient · General Payments record
DONALD GENE HOLBROOKS
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family
General Payments · PY2021–2024
$4,316.73
- Reported across 168 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $637.54 | 35 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $237.31 | 15 |
| Novo Nordisk AS | $88.66 | 5 |
| Lundbeck LLC | $87.87 | 4 |
| EISAI INC. | $52.24 | 2 |
| ACADIA Pharmaceuticals Inc | $51.65 | 2 |
| PFIZER INC. | $46.37 | 2 |
| GlaxoSmithKline, LLC. | $26.37 | 2 |
| Genentech USA, Inc. | $18.41 | 1 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $14.96 | 1 |
| Exact Sciences Corporation | $13.70 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (35)
Sorted by paying entity, then date · as published by CMS
Program year 2024 202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $15.91 | 01/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107347010 | CMS |
| ABBVIE INC. | $6.28 | 02/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107347012 | CMS |
| ABBVIE INC. | $13.24 | 03/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107347014 | CMS |
| ABBVIE INC. | $10.64 | 04/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107347016 | CMS |
| ABBVIE INC. | $23.18 | 06/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107347018 | CMS |
| ABBVIE INC. | $6.07 | 06/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107347020 | CMS |
| ABBVIE INC. | $24.49 | 07/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107347022 | CMS |
| ABBVIE INC. | $16.69 | 08/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107347024 | CMS |
| ABBVIE INC. | $10.77 | 09/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107347026 | CMS |
| ABBVIE INC. | $24.96 | 09/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107347028 | CMS |
| ABBVIE INC. | $16.26 | 10/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107347030 | CMS |
| ABBVIE INC. | $26.48 | 11/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107347032 | CMS |
| ABBVIE INC. | $9.68 | 11/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107347034 | CMS |
| ABBVIE INC. | $24.28 | 12/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107347036 | CMS |
| ABBVIE INC. | $8.38 | 12/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107347038 | CMS |
| ACADIA Pharmaceuticals Inc | $30.49 | 08/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148005454 | CMS |
| ACADIA Pharmaceuticals Inc | $21.16 | 10/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148005456 | CMS |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $14.96 | 08/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117975003 | CMS |
| Eisai Inc. | $24.16 | 02/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110800151 | CMS |
| Eisai Inc. | $28.08 | 08/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110800153 | CMS |
| Exact Sciences Corporation | $13.70 | 02/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114460279 | CMS |
| Genentech USA, Inc. | $18.41 | 10/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133155579 | CMS |
| GlaxoSmithKline, LLC. | $13.20 | 05/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116570991 | CMS |
| GlaxoSmithKline, LLC. | $13.17 | 08/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116363155 | CMS |
| Lundbeck LLC | $20.70 | 03/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146035946 | CMS |
| Lundbeck LLC | $19.15 | 06/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146035948 | CMS |
| Lundbeck LLC | $23.47 | 11/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146035950 | CMS |
| Lundbeck LLC | $24.55 | 12/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146035952 | CMS |
| Novo Nordisk Inc | $14.78 | 01/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100315706 | CMS |
| Novo Nordisk Inc | $20.06 | 03/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100617314 | CMS |
| Novo Nordisk Inc | $22.83 | 09/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100278756 | CMS |
| Novo Nordisk Inc | $17.58 | 11/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100424005 | CMS |
| Novo Nordisk Inc | $13.41 | 11/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100490737 | CMS |
| PFIZER INC. | $24.33 | 06/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131600249 | CMS |
| PFIZER INC. | $22.04 | 08/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131866460 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.